✦ LIBER ✦

Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix

✍ Scribed by Carlo Scarabelli; Salvatore Tumolo; Antonino De Paoli; Sergio Frustaci; Elio Campagnutta; Sandro Morassut; Gianni Franchin; Diana Crivellari; Francesco Sopracordevole; Giovanni Lo Re; Eligio Grigoletto; Silvio Monfardini

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 685 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870701)60:1<25::aid-cncr2820600106>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced and recurrent squa

Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin

✍ Mark A. Rettenmaier; Mark F. Moran; Nilam F. Ramsinghani; Martin Colman; Nissar 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 3 views

Twelve patients with primary or locally recurrent squamous carcinoma of the cervix were treated with constant internal iliac artery infusion of cisplatin (CDDP) via a totally implantable chemotherapy pump. Seven previously untreated patients received standard external and interstitial radiotherapy (

Phase I/II study of intravenous nedaplat

Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma

✍ Susumu Adachi; Toshitada Ogasawara; Eiko Wakimoto; Yoshiyuki Tsuji; Tadashi Take 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Hepatic arterial infusion of 5-fluoroura

Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein

✍ Toshiyuki Itamoto; Hideki Nakahara; Hirotaka Tashiro; Naoki Haruta; Toshimasa As 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Phase II trial of chemotherapy with 5-fl

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or